Horizon Therapeutics plc has launched the #RAREis Representation program, aiming to enhance equity in the rare disease community. The program features a new website section for community feedback on issues affecting rare disease equity, which will inform future initiatives. A webcast conversation on these topics will occur on February 28. As part of its ongoing commitment, Horizon will also engage through global Rare Disease Day efforts to raise awareness. The initiative addresses the challenges faced by approximately 400 million individuals affected by rare diseases worldwide.
Summary not available.
WTW (NASDAQ: WTW) will announce its fourth-quarter and full-year financial results on February 8, 2022, before market opening. A conference call will follow at 9:00 a.m. Eastern Time to discuss the results, with a live stream available on their Investor Relations website. WTW is a global advisory and solutions company with over 46,000 employees servicing clients in more than 140 countries, focusing on managing risk and optimizing benefits.
Summary not available.
Summary not available.
WTW has announced the establishment of a new Crisis Management unit following the merger of its Special Contingency Risks (SCR) and Terror and Political Violence teams. This segment will operate under the Financial Solutions Global Line of Business and will be led by Jo Holliday. The unit aims to provide specialized crisis and contingency risk management services to multinational clients, addressing areas such as terrorism, political violence, and personal accidents. This move comes in response to a survey indicating that over 50% of clients consider security and geopolitical risks as significant concerns.
Willis Towers Watson (NASDAQ: WLTW) announced that its ticker symbol will change to 'WTW' on January 10, 2022. This change reflects the company's efforts to simplify operations and enhance agility as it operates independently. CEO Carl Hess stated that the new symbol represents a fresh direction for the company. Shareholders do not need to take any action regarding this change, and the company's ordinary shares will remain listed on Nasdaq with the CUSIP unchanged. Willis Towers Watson continues to provide advisory solutions globally.
Willis Towers Watson reported its first positive annual M&A performance in five years for 2021, with 1,047 completed deals valued over $100 million, up from 674 the previous year. The average outperformance against the World Index was +1.4 percentage points. North America closed 614 deals, while Asia Pacific and Europe saw significant improvements. Key trends for 2022 include ESG-driven M&A, acceleration of digital transformation, and challenges from inflation and supply chain disruptions. Overall, M&A activity is expected to remain strong.
Willis Towers Watson reports a significant improvement in the funded status of the largest corporate defined benefit pension plans in the U.S., reaching 96% at the end of 2021, a sharp rise from 88% in 2020. This marks the highest level since 2007. The projected funding deficit decreased to $63 billion from $232 billion in 2020, while pension obligations fell 8% to approximately $1.74 trillion. Average investment returns for 2021 stood at 8.9%, led by a 29% growth in domestic large-cap equities.
Willis Towers Watson (NASDAQ:WLTW) has launched a new Risk and Analytics model targeting the trade credit market. This innovative model evaluates clients’ trade receivables to forecast potential losses, providing insights on risk ratings, probability of default, and customizable credit insurance ROI calculations. It caters to a wide range of users, from businesses on open account terms to financial institutions and those involved in mergers and acquisitions. Scott Ettien emphasized the model’s role in helping clients leverage Trade Credit Insurance as an effective risk management tool.